Shanghai Guangsheng Pharmaceutical
Develops and commercializes innovative photosensitizers for photodynamic therapy, targeting conditions such as esophageal cancer, colorectal cancer, brain glioma, and HSIL.
HQ location
Shanghai, China
Launch date
Enterprise value
$69m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
* | CNY20.0m Valuation: CNY500m | Early VC | |
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads